Practice
Monoclonal gammopathy of undetermined significance
Sébastien Anguille and Christian Bryant
CMAJ October 15, 2013 185 (15) 1345; DOI: https://doi.org/10.1503/cmaj.122090
Sébastien Anguille
Division of Hematology (Anguille), Antwerp University Hospital, Antwerp, Belgium; and Dendritic Cell Biology and Therapeutics Group (Bryant), ANZAC Research Institute, Sydney, Australia
MDChristian Bryant
Division of Hematology (Anguille), Antwerp University Hospital, Antwerp, Belgium; and Dendritic Cell Biology and Therapeutics Group (Bryant), ANZAC Research Institute, Sydney, Australia
MDArticle Figures & Tables
There are no figures or tables available.
In this issue
Article tools
Respond to this article
Monoclonal gammopathy of undetermined significance
Sébastien Anguille, Christian Bryant
CMAJ Oct 2013, 185 (15) 1345; DOI: 10.1503/cmaj.122090
Jump to section
- Article
- Monoclonal gammopathy of undetermined significance is a diagnosis of exclusion
- Monoclonal gammopathy of undetermined significance is a common problem
- All cases should be investigated
- Tools are available to assess the risk of evolution into malignant disease
- No known treatment exists and follow-up should be individualized
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.